Recorded June 14, 2012, free download
Reimbursement Insights From ASCO: Key take-aways that may shift coverage decisions
More than 20,000 oncology professionals gathered in Chicago June 1-5, 2012 for the American Society of Clinical Oncology annual meeting to discuss the latest cancer research.
Real Endpoints was there too, sifting through poster presentations, panel discussions, and scientific sessions to identify the critical topics impacting cancer drug reimbursement today—and in the future. Our analysts summarized the key “take-home” lessons from the meeting and their probable impact on the uptake of products—both those already on the market as well as in development—in a concise, one-hour webinar on June 14th.
ASCO was simply too big and too packed to see and hear everything of interest. Take advantage of the RE team’s ability to synthesize and analyze the top ASCO findings to help you understand the potential reimbursement shifts that may result. Download the audio/video presentation free…
Recorded March 20, 2012, free download
Managing Cancer Costs…The Pathways Experiment
Hear first-hand from payers, providers, and pathway developers about how cancer pathways work, the financial incentives driving adoption, and why 2012 will be a critical year for the concept. Experts like Aetna’s Dr. Ira Klein, The US Oncology Network’s Dr. Barry Brooks, UnitedHealth’s Dr. Lee Newcomer, Medco’s Dr. Milanya Subar, and eviti’s Dr. Arlene Forastiere will also discuss the challenges they’ve faced implementing these programs and the strategic implications for drug makers, payers, and risk-sharing providers.